© 2021 MJH Life Sciences and Endocrinology Network. All rights reserved.
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
September 28, 2020
An associate professor from University of Toronto discusses whose responsibility it is to prescribe SGLT2 inhibitors to patients.
September 25, 2020
A study presented at EASD 2020 examines the impact of increased exercise capacity on risk of all-cause mortality among more than 4k patients with type 2 diabetes.
September 23, 2020
Data from a group of type 1 diabetics from a diabetes center in Italy suggests time off work and in lockdown could have been helped some patients improve glycemic control.
Research presented at EASD 2020 provides an updated estimate of the life years lost as a result of type 1 and type 2 diabetes, respectively, among patients in the UK.
September 22, 2020
A study from EASD 2020 found type 1 diabetes was associated with a 33% increase in risk of falls while type 2 diabetes was associated with a 19% increase in risk.
A study from EASD 2020 suggests patients with RA could be at a nearly 25% increase in risk of developing type 2 diabetes later in life.